Survivors >30 days versus non-survivors
| Non-survivors | Survivors | p Value | |
|---|---|---|---|
| N | 21 | 110 | |
| Gender (% women) | 8 (38%) | 36 (34%) | 0.67 |
| Age (years) | 63±9 | 59±11 | 0.14 |
| Ejection fraction (%) | 49±13 | 56±9 | 0.024 |
| Preoperative heart rate (BPM) | 69±21 | 73±17 | 0.39 |
| Preoperative systolic blood pressure (mm Hg) | 114±30 | 128±33 | 0.039 |
| Preoperative diastolic blood pressure (mm Hg) | 62±12 | 72±22 | 0.07 |
| Preoperative haemoglobin (g/l) | 133±16 | 134±1 5 | 0.72 |
| Platelet count (×109/l) | 201±72 | 233±77 | 0.11 |
| Serum creatine (μmol/l) | 105±75 | 89±28 | 0.10 |
| Cardiac tamponade | 9 (43%) | 22 (20%) | 0.035 |
| Intramural haematoma | 4 (19%) | 18 (16%) | 0.76 |
| Any antiplatelet treatment | 8 (38%) | 34 (31%) | 0.52 |
| Double antiplatelet therapy | 7 (33%) | 16 (15%) | 0.038 |
| Perioperative aprotinin treatment | 2 (9.5%) | 22 (20%) | 0.19 |
| CBP (min) | 217±76 | 195±57 | 0.15 |
| Circulatory arrest (min) | 27±10 | 25±12 | 0.45 |
| Intraoperative bleeding (ml) | 2400 (500–5000) | 1000 (500–2500) | 0.020 |
| Postoperative bleeding (ml) | 2065 (580–2615) | 550 (383–1198) | 0.007 |
| Postoperative bleeding >1000 ml | 8 (67%) | 33 (30%) | 0.011 |
| Transfusion RBC (u) | 24 (14–38) | 9 (3–16) | <0.001 |
| Transfusion plasma (u) | 20 (10–41) | 9 (3–17) | 0.006 |
| Transfusion platelets (u) | 7 (3–9) | 4 (2–6) | 0.07 |
| Transfusions total (u) | 48 (33–94) | 21.5 (9–39) | 0.002 |
| Stroke | 4 (19%) | 13 (12%) | 0.58 |
| Massive bleeding | 12 (57%) | 21 (19%) | <0.001 |
Mean±SD, median (IQR) or number and %.
BPM, beats per minute; CBP, cardiopulmonary bypass; RBC, red blood cell.